AbbVie (NASDAQ:ABBV)‘s stock had its “buy” rating reaffirmed by analysts at Bank of America Corp. in a research report issued to clients and investors on Tuesday, Stock Ratings Network.com reports. They currently have a $56.00 target price on the stock, up from their previous target price of $53.00. Bank of America Corp.’s price objective indicates […]
AbbVie Rating Reiterated by Bank of America Corp. (ABBV) is a post from: Zolmax
The post AbbVie Rating Reiterated by Bank of America Corp. (ABBV) appeared first on Zolmax.